UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000049317
Receipt number R000056153
Scientific Title Investigation of the feasibility of acupuncture and moxibustion treatment on short-term intensive exercise program in care prevention
Date of disclosure of the study information 2022/10/25
Last modified on 2022/10/25 19:25:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigation of the feasibility of acupuncture and moxibustion treatment on short-term intensive exercise program in care prevention

Acronym

Investigation of the feasibility of acupuncture and moxibustion treatment on short-term intensive exercise program in care prevention

Scientific Title

Investigation of the feasibility of acupuncture and moxibustion treatment on short-term intensive exercise program in care prevention

Scientific Title:Acronym

Investigation of the feasibility of acupuncture and moxibustion treatment on short-term intensive exercise program in care prevention

Region

Japan


Condition

Condition

pain disorder

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study was to explore the feasibility of combining acupuncture and moxibustion treatment in a short-term intensive exercise program for care prevention. The subjects were residents of the town of Yanaizu, Fukushima Prefecture, aged 65 years or older, who were not certified for long-term care. This study will examine the safety and feasibility of acupuncture and moxibustion treatment in combination with exercise therapy for long-term care prevention, and will also explore the possibility of introducing this treatment into future long-term care projects.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Evaluate the frequency of adverse events with respect to safety in the practice of acupuncture and moxibustion.
Acupuncture treatments will be performed once a week for a total of 14 weeks, so the evaluation will be conducted in conjunction with each acupuncture treatment.

Key secondary outcomes

1. Assess the subject's pain using a visual analogue scale.
2. Quality of Life (QOL) assessment: QOL is assessed using the SF-8 (MOS 8-Item Short-Form Health Survey), with scores calculated from the SF-8.
Secondary outcomes will be assessed at baseline (week 1) and at 16 weeks.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Acupuncture treatment to the pain site complained by the subject.
Acupuncture treatments will be performed once a week for a total of 14 treatments.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit

120 years-old >

Gender

Male and Female

Key inclusion criteria

1 Persons 65 years of age or older.
2 Those who have not received nursing care certification.
3 Gender is not a factor.
4 Subjects with chronic pain and VAS of 20mm or more.

Key exclusion criteria

1 Research subjects with poorly controlled cancer.
2 Research subjects who have difficulty communicating due to mental disorders.
3 Research subjects with allergies to metals.
4 Research subjects who do not have pain.
5 Subjects with chronic pain but with a VAS of less than 20mm.

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Tadamichi
Middle name
Last name Mitsuma

Organization

Aizu Medical Center, Fukushima Medical University

Division name

Department of Kampo Medicine

Zip code

969-3492

Address

21-2 Maeda, Kawahigashi, Aizuwakamatsu city Fukushima

TEL

0242752100

Email

tmitsuma@fmu.ac.jp


Public contact

Name of contact person

1st name Masao
Middle name
Last name Suzuki

Organization

Aizu Medical Center, Fukushima Medical University

Division name

Department of Kampo Medical Research Institute

Zip code

969-3492

Address

21-2 Maeda, Kawahigashi, Aizuwakamatsu city Fukushima

TEL

0242752100

Homepage URL


Email

masuzuki@fmu.ac.jp


Sponsor or person

Institute

Aizu Medical Center, Fukushima Medical University

Institute

Department

Personal name



Funding Source

Organization

Fukushima Medical University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Fukushima Medical University School of Medicine

Address

1-Hikarigaoka, Fukushima

Tel

024-547-1041

Email

fmucrb@fmu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

社会福祉法人両沼厚生会 柳津町高齢者生活福祉センター(福島県)


Other administrative information

Date of disclosure of the study information

2022 Year 10 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2022 Year 07 Month 31 Day

Date of IRB

2022 Year 10 Month 03 Day

Anticipated trial start date

2022 Year 11 Month 05 Day

Last follow-up date

2024 Year 01 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 10 Month 25 Day

Last modified on

2022 Year 10 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056153